Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

6 structures for Q9CPN8

Entry ID Method Resolution Chain Position Source
7VKL X-ray 195 A A 192-355 PDB
7VSJ X-ray 238 A A 1-161 PDB
7YEW X-ray 250 A A/C 1-161 PDB
7YEX X-ray 200 A A 1-160 PDB
7YEY X-ray 185 A A 192-355 PDB
AF-Q9CPN8-F1 Predicted AlphaFoldDB

23 variants for Q9CPN8

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388831696 95 E>* No EVA
rs3388823827 97 L>M No EVA
rs3388826236 116 D>V No EVA
rs3388830424 126 Y>F No EVA
rs3396786162 145 E>G No EVA
rs3388826536 181 R>G No EVA
rs3388823848 214 E>K No EVA
rs3388807939 224 Q>H No EVA
rs3388823299 253 T>S No EVA
rs3388796965 305 D>N No EVA
rs3388823868 314 P>Q No EVA
rs3388830371 330 K>NG* No EVA
rs3388831683 356 A>T No EVA
rs3396699980 362 A>S No EVA
rs3388808014 402 Q>E No EVA
rs3388831689 411 F>I No EVA
rs3388797022 453 M>L No EVA
rs3388829953 506 G>* No EVA
rs3388816971 511 N>K No EVA
rs3388823223 528 T>R No EVA
rs3388813019 539 I>M No EVA
rs3388826218 555 E>K No EVA
rs229160147 563 H>Q No EVA

No associated diseases with Q9CPN8

5 regional properties for Q9CPN8

Type Name Position InterPro Accession
domain TolB, N-terminal 23 - 121 IPR007195
repeat WD40-like beta propeller 203 - 223 IPR011659-1
repeat WD40-like beta propeller 237 - 272 IPR011659-2
repeat WD40-like beta propeller 281 - 315 IPR011659-3
repeat WD40-like beta propeller 369 - 396 IPR011659-4

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Cytoplasm
  • Cytoplasm, P-body
  • Cytoplasm, Stress granule
  • Found in lamellipodia of the leading edge, in the perinuclear region, and beneath the plasma membrane
  • The subcytoplasmic localization is cell specific and regulated by cell contact and growth
  • Localized at the connecting piece and the tail of the spermatozoa
  • In response to cellular stress, such as oxidative stress, recruited to stress granules
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytoplasmic stress granule A dense aggregation in the cytosol composed of proteins and RNAs that appear when the cell is under stress.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
P-body A focus in the cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. Protein and RNA localized to these foci are involved in mRNA degradation, nonsense-mediated mRNA decay (NMD), translational repression, and RNA-mediated gene silencing.

4 GO annotations of molecular function

Name Definition
mRNA 3'-UTR binding Binding to a 3' untranslated region of an mRNA molecule.
mRNA 5'-UTR binding Binding to an mRNA molecule at its 5' untranslated region.
mRNA binding Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
N6-methyladenosine-containing RNA binding Binding to an RNA molecule modified by N6-methyladenosine (m6A), a modification present at internal sites of mRNAs and some non-coding RNAs.

6 GO annotations of biological process

Name Definition
CRD-mediated mRNA stabilization An mRNA stabilization process in which one or more RNA-binding proteins associate with a sequence in the open reading frame called the coding region instability determinant (CRD).
mRNA transport The directed movement of mRNA, messenger ribonucleic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
nervous system development The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
regulation of gene expression Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
regulation of RNA metabolic process Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving RNA.
regulation of translation Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA.

10 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O42254 IGF2BP1 Insulin-like growth factor 2 mRNA-binding protein 1 Gallus gallus (Chicken) PR
Q5ZLP8 IGF2BP3 Insulin-like growth factor 2 mRNA-binding protein 3 Gallus gallus (Chicken) PR
Q9NZI8 IGF2BP1 Insulin-like growth factor 2 mRNA-binding protein 1 Homo sapiens (Human) PR
Q9Y6M1 IGF2BP2 Insulin-like growth factor 2 mRNA-binding protein 2 Homo sapiens (Human) PR
O00425 IGF2BP3 Insulin-like growth factor 2 mRNA-binding protein 3 Homo sapiens (Human) PR
O88477 Igf2bp1 Insulin-like growth factor 2 mRNA-binding protein 1 Mus musculus (Mouse) PR
Q5SF07 Igf2bp2 Insulin-like growth factor 2 mRNA-binding protein 2 Mus musculus (Mouse) PR
P60335 Pcbp1 Poly(rC)-binding protein 1 Mus musculus (Mouse) PR
Q8CGX0 Igf2bp1 Insulin-like growth factor 2 mRNA-binding protein 1 Rattus norvegicus (Rat) PR
Q08CK7 igf2bp1 Insulin-like growth factor 2 mRNA-binding protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MNKLYIGNLS DHAGPADLES VFKDAKIPVA GPFLVKTGYA FVDCPDEGWA LKAIEALSGK
70 80 90 100 110 120
MELHGKPMEV EHSVPKRQRI RKLQIRNIPP HLQWEVLDSL LVQYGVVESC EQVNTDSETA
130 140 150 160 170 180
VVNVTYSSKD QARQALDKLN GFQLENFTLK VAYIPDETAA QQNPSPQLRG RRGPGQRGSS
190 200 210 220 230 240
RQASPGSVSK QKPCDLPLRL LVPTQFVGAI IGKEGATIRN ITKQTQSKID VHRKENTGAA
250 260 270 280 290 300
EKSITILSTP EGTSAACKSI LEIMHKEAQD IKFTEEIPLK ILAHNNFVGR LIGKEGRNLK
310 320 330 340 350 360
KIEQDTDTKI TISPLQELTL YNPERTITVK GSVETCAKAE EEIMKKIRES YENDIASMNL
370 380 390 400 410 420
QAHLIPGLNL NALGLFPPTS GMPPPTSGPP STLTPPYPQF EQSETETVHL FIPALSVGAI
430 440 450 460 470 480
IGKQGQHIKQ LSRFAGASIK IAPAEAPDAK VRMVIITGPP EAQFKAQGRI YGKIKEENFV
490 500 510 520 530 540
SPKEEVKLEA HIRVPSFAAG RVIGKGGKTV NELQSLSSAE VVVPRDQTPD ENDQVVVKIT
550 560 570
GHFYACQVAQ RKIQEILTQV KQHQQQKALQ SGPPQSRRK